Immediate Impact

7 standout
Sub-graph 1 of 4

Citing Papers

A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis
2024 Standout
Gut Microbiota Dysbiosis, Oxidative Stress, Inflammation, and Epigenetic Alterations in Metabolic Diseases
2024 Standout
1 intermediate paper

Works of Luca Panchetti being referenced

Statin intolerance in heterozygous familial hypercolesterolemia with cardiovascular disease: After PCSK-9 antibodies what else?
2017

Author Peers

Author Last Decade Papers Cites
Luca Panchetti 139 27 2 20 19 149
Margarida Pujol‐López 201 26 3 51 32 213
Mariëlle Kloosterman 242 18 2 23 20 247
Carolina Hoyos 145 27 37 28 153
Carlos D. Matos 142 23 1 37 30 148
Irum Kotadia 165 17 14 10 19 184
Umberto Startari 206 34 13 22 25 225
Ahmed S Beela 169 29 2 15 18 186
Halim Marzak 114 43 14 14 17 163
Nuria Basterra 209 24 34 39 20 251
Fabrizio Caravati 145 29 8 27 159

All Works

Loading papers...

Rankless by CCL
2026